Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStart™ Vaccine Platform

Print E-mail
By William Kent   
Wednesday, 22 October 2014 19:04
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 22, 2014.
Read more...
 

Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cell Therapy Product Line

Print E-mail
By Mary Davila   
Tuesday, 21 October 2014 18:35

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 21, 2014.

Read more...
 

CytRx Announces Publication of Phase 1b/2 Aldoxorubicin; NewLink Genetics Announces Licensing Agreement For Development Of NLG919

Print E-mail
By Marilyn Mullen   
Monday, 20 October 2014 19:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 20, 2014.
Read more...
 

Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® and GAZYVA®; Infinity Reports Data From Duvelisib Phase 2a Study

Print E-mail
By Josh Gee   
Thursday, 16 October 2014 18:39

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 16, 2014.

Read more...
 

TherapeuticsMD Announces Presentation Of Positive Phase 2 On TX-004HR; Advaxis Provides Clinical Update For ADXS-HPV

Print E-mail
By William Kent   
Wednesday, 15 October 2014 19:09
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 15, 2014.
Read more...
 

Medtronics Reports FDA Approval Of Capsurefix Novus MRI Surescane 5076; BioLife Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy

Print E-mail
By Marilyn Mullen   
Tuesday, 14 October 2014 20:07
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 14, 2014.
Read more...
 

Lipocine Announces Positive Results In Phase 2a Study Of LPCN; Kite Reports Positive Results With Anti-CD19

Print E-mail
By Josh Gee   
Monday, 13 October 2014 18:51

Below is a look at some of the headlines for companies that made news in the healthcare sector on October 13, 2014.

Read more...
 

Eisai And Arena Announce Publication Of Phase 3 Clinical Trial Analysis Of BELVIQ; EXACT Shares On The Move Following FDA Approval

Print E-mail
By Marilyn Mullen   
Friday, 10 October 2014 17:50
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 10, 2014.
Read more...
 

Rockwell Announces FDA Advisory Committee Review Of Triferic; Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data

Print E-mail
By William Kent   
Thursday, 09 October 2014 19:24
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 9, 2014.
Read more...
 

Amgen Declares a Head-to-Head Phase III Win for Humira biosimilar; Conatus Reports Acceptance of Abstract for AASLD Meeting

Print E-mail
By David Fowler   
Wednesday, 08 October 2014 18:57
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 8, 2014.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 349

Newsletter

BioMedReports Harvoni Approved For The Treatment Of Chronic Hepatitis C; TapImmune Provides Update on PolyStart™ Vaccine Pla... http://t.co/UoFNaJuTuD
2hreplyretweetfavorite
BioMedReports Active Stocks: Amgen, Alkermes, Nanosphere, Biogen Idec, Regulus Therapeutics: U.S. stocks turned lower in af... http://t.co/gHIHogcGHP
3hreplyretweetfavorite
BioMedReports Agios Pharma Reports Initiation of Phase 1/2 Clinical Trial of AG-221; Pluristem Advances its Second Major Cel... http://t.co/qkvJGEUaT5
navigation
Benzinga.com supporter Seeking Alpha Certified